Altria Group Inc
Q1 2025 Earnings
Market Reaction
S&P 500 over the same 30 days: +6.33%.
Did MO Beat Earnings? Q1 2025 Results
Altria Group delivered a stronger-than-expected first quarter, with adjusted diluted EPS of $1.23 clearing the $1.1881 consensus estimate by 3.53%, while revenue of $5.26 billion ran 13.95% ahead of the $4.62 billion Wall Street expected and grew 11.5% year-over-year — a result that underscores the resilience of the tobacco giant's pricing power even as cigarette volumes erode. The headline story, however, carried a significant asterisk: an $873 million non-cash goodwill impairment tied to its NJOY e-vapor unit — triggered by an ITC importation ban on NJOY ACE products taking effect March 31 — dragged reported diluted EPS down 47.9% to $0.63, masking otherwise steady underlying progress. Adjusted smokeable segment income grew 2.7% despite domestic cigarette shipment volume falling 13.7%, while on! nicotine pouch shipments surged 18.0%, reflecting the accelerating structural shift toward smoke-free alternatives. <a href="https://247wallst.com/investing/2025/07/30/live-dividend-giant-altria-nyse-mo-releases-earnings-today/">Altria's dividend standing</a> remained intact as the company reaffirmed full-year 2025 adjusted EPS guidance of $5.30 to $5.45, representing 2% to 5% growth, even as it assumes ACE does not return to market this year.
- Higher pricing in smokeable products offset lower shipment volume
- Lower per unit settlement charges in smokeable products
- Fewer shares outstanding drove adjusted EPS growth
- Lower adjusted tax rate (23.5% vs 24.6% prior year)
- on! nicotine pouches shipment volume grew 18.0% with retail share up 1.8 points to 8.8%
- NJOY consumables shipment volume grew 23.9% to 13.5 million units
- Smokeable products adjusted OCI margins expanded 4.2 percentage points to 64.4%
“Our highly profitable traditional tobacco businesses performed well in a challenging environment in the first quarter. The smokeable products segment delivered solid adjusted operating companies income growth behind the strength of Marlboro. In the oral tobacco products segment, on! maintained momentum in a competitive marketplace as Helix invested strategically behind the brand. And shareholders continued to benefit from strong cash returns through dividends and share repurchases, while we invested in pursuit of our Vision.”
Altria CEO, on the earnings call
Forward Guidance & Outlook
Altria reaffirmed 2025 full-year adjusted diluted EPS guidance of $5.30 to $5.45, representing 2% to 5% growth from a recast 2024 base of $5.19 (now excluding amortization of intangibles). Guidance contemplates the estimated impact of increased tariffs, assumes limited impact on volumes from illicit e-vapor enforcement, and assumes NJOY ACE does not return to the marketplace in 2025. The range includes reinvestment of anticipated cost savings from the Optimize & Accelerate initiative, lower expected net periodic benefit income, and continued investments in smoke-free product development, marketplace activities, and regulatory preparation. The company noted the external environment remains dynamic, with monitoring of economic conditions including cumulative inflation and tariff impacts, adult tobacco consumer dynamics, illicit product enforcement, and regulatory/legislative developments.
MO YoY Financials
MO Revenue by Segment
Figures from SEC filings and company reports. Not investment advice.